--Manuscript Draft-- Primary Aldosteronism; adrenal vein sampling; aldosterone producing adenoma. Brisbane, Queensland, AUSTRALIA

Similar documents
Adrenal Vein Sampling: A Critical Tool for Subtyping Primary Aldosteronism

ADRENAL VEIN SAMPLING: AN INTEGRAL PART OF MANAGING COMPLICATED ADRENAL HYPERTENSION- SAFE? WORTH IT?

Primary Aldosteronism: screening, diagnosis and therapy

Updates in primary hyperaldosteronism and the rule

Primary Aldosteronism

AVS and IPSS: The Basics and the Pearls William F. Young, Jr., MD, MSc Professor of Medicine Mayo Clinic College of Medicine Rochester, MN, USA

Updates in primary hyperaldosteronism and the rule

AVS and IPSS: The Basics and the Pearls

Primary aldosteronism (PA), the most common endocrine

Outpatient Fludrocortisone Suppression Test: A Safe and Effective Alternative to Inpatient

Diagnosis of primary aldosteronism (PA), the most frequent

Primary aldosteronism (PA) is currently believed to be

Upon completion, participants should be able to:

Adrenal vein sampling (AVS) is considered the gold

Clarification of hypertension Diagnosis of primary hyperaldosteronism

Diagnosis of primary aldosteronism (PA), the most frequent

Adrenal Vein Sampling

Amplified Screening and Workup Protocol for Primary Aldosteronism: A Strategy to Improve

Diagnostic Accuracy of Adrenal Venous Sampling in Comparison with Other Parameters in Primary Aldosteronism

Spectrum of Hypertension & Hypokalemia

Year 2004 Paper two: Questions supplied by Megan 1

Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes

About 20% of the Canadian population

ENDOCRINE FORMS OF HYPERTENSION. Michael Stowasser

PREOPERATIVE DIAGNOSIS AND LOCALIZATION OF ALDOSTERONE-PRODUCING ADENOMA BY ADRENAL VENOUS SAMPLING AFTER ADMINISTRATION OF METOCLOPRAMIDE

Primary aldosteronism clinical practice guidelines: a re-appraisal The Management of Primary Aldosteronism

Changes in the clinical manifestations of primary aldosteronism

A clinical prediction score for diagnosing unilateral primary Aldosteronism may not be generalizable

Is Adrenal Venous Sampling Necessary in All Patients with Hyperaldosteronism before Adrenalectomy?

Primary aldosteronism (PA), the most common cause of

Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios

ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism

Resistant hypertension is defined as blood. Primary Hyperaldosteronism Decoded: A Case of Curable Resistant Hypertension.

Primary Aldosteronism. Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism

Abstract. Introduction

A 64 year old man referred for evaluation of suspected hyperaldosteronism

Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota

Adrenal Venous Sampling Evaluation of the German Conn s Registry

Primary Aldosteronism & Implications for Primary Hypertension

Prevalence of Hyperaldosteronism in Primary Care Patients with Resistant Hypertension

How to Recognize Adrenal Disease

Venous sampling technique in Endocrinology: a renewed technique

Endocrine hypertensionmolecules. Marie Freel Caledonian Endocrine Society Meeting 29 th November 2015

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas

Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure

The Work-up and Treatment of Adrenal Nodules

Original Article. Roberto FOGARI 1), Paola PRETI 1), Annalisa ZOPPI 1), Andrea RINALDI 1), Elena FOGARI 1), and Amedeo MUGELLINI 1) Introduction

Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study

Adrenal incidentaloma

Endocrine Hypertension

Studies both in vivo and in vitro have demonstrated that

Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?

Primary aldosteronism (PA) is a syndrome caused by

FOUR CASES OF HYPOVOLEMIC RENIN-ALDOSTERONE AXIS DEFICIENCY WITHOUT HYPERKALEMIA FOLLOWING UNILATERAL ADRENALECTOMY FOR PRIMARY ALDOSTERONISM

27 F with new onset hypertension and weight gain. Rajesh Jain Endorama 10/01/2015

Case report. Open Access. Abstract

Primary and secondary hyperaldosteronism. Zsolt Turóczi, M.D. 2nd Department of Internal Medicine

C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management

Adrenal Mass. Cynthia Kwong SUNY Downstate Medical Center Grand Rounds October 13, 2016

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-

Adrenal incidentaloma guideline for Northern Endocrine Network

Clinical Pathological Conference

Hyperaldosteronism: recent concepts, diagnosis, and management

Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone

Case Based Urology Learning Program

Recent studies have demonstrated that primary aldosteronism

Although debate on the true prevalence of primary aldosteronism

The endocrine system is made up of a complex group of glands that secrete hormones.

AN INDIVIDUALIZED APPROACH TO THE EVALUATION AND MANAGEMENT OF PRIMARY ALDOSTERONISM

Indications for Surgical Removal of Adrenal Glands

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP

Patients with primary aldosteronism (PA) are at a higher

A Case of Primary Aldosteronism Due to Unilateral Adrenal Hyperplasia

Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism

A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients

Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism

William F. Young, Jr., MD, MSc Professor of Medicine, Mayo Clinic, Rochester, MN USA

A Rare Case of ACTH-independent Macronodular Adrenal Hyperplasia Associated with Aldosterone-producing Adenoma

Prospective Study on the Prevalence of Secondary Hypertension among Hypertensive Patients Visiting a General Outpatient Clinic in Japan

Dimitrios Linos, M.D., Ph.D. Professor of Surgery National & Kapodistrian University of Athens

Secondary Hypertension: A Real World Approach

Adrenal venous sampling as used in a patient with primary pigmented nodular adrenocortical disease

A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing s Syndrome without Cardiovascular Complications

ADRENAL INCIDENTALOMA. Jamii St. Julien

DIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING

Aldosterone synthase inhibitors. John McMurray BHF Cardiovascular Research Centre University of Glasgow

The Leeds Teaching Hospitals NHS Trust Adrenalectomy

Trust Guideline for the Investigation of Incidental Adrenal Masses in Adults

THE RESULTS OF SURGICAL TREATMENT IN NODULAR GOITRE

How to approach resistant hypertension. Teh-Li Huo, M.D., Ph.D.

How do I investigate suspected secondary hypertension? Marie Freel RCP Update in Medicine 23 rd November 2016

Great Ormond Street Hospital for Children NHS Foundation Trust

Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing

EndocrinologyUpdate. Endoscopic Transnasal Surgical Technique for Pituitary Tumors

Too Much of a Good Thing: A Woman with Hypertension and Hypokalemia

Prevalence of adrenal incidentaloma a methodologic comparison of EMR query strategies

Predictors of Successful Outcome After Adrenalectomy for Primary Aldosteronism

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM

Transcription:

Journal of Hypertension Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma --Manuscript Draft-- Manuscript Number: Full Title: Article Type: Keywords: Corresponding Author: JH-D-13-00085R1 Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma Original Manuscript Primary Aldosteronism; adrenal vein sampling; aldosterone producing adenoma Michael Stowasser, MBBS, FRACP, PhD Brisbane, Queensland, AUSTRALIA Corresponding Author Secondary Information: Corresponding Author's Institution: Corresponding Author's Secondary Institution: First Author: Martin Wolley, MBChB First Author Secondary Information: Order of Authors: Martin Wolley, MBChB Richard D Gordon, MD, PhD Eduardo Pimenta, MD, PhD Nicholas Daunt, MBBS Gregory Slater, MBBS Ashraf Ahmed, MBChB, PhD Michael Stowasser, MBBS, PhD Order of Authors Secondary Information: Abstract: Objectives: In primary aldosteronism (PA), adrenal vein sampling (AVS) suggests unilateral aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is peripheral on one side and 2 times peripheral on the other. When A/F ratios are lower bilaterally than peripheral despite adequate samples (adrenal venous cortisol 3 times peripheral), we recommend repeat AVS. This study aimed to determine the frequency of this occurrence and outcomes in such cases. Methods: We performed a retrospective observational study of all cases of primary aldosteronism undergoing initial AVS over a 34 year period. Results: Initial AVS in 1397 patients returned satisfactory, discriminatory results in 1066 (76.3%) but 37 patients (2.6%) had adequate samples but bilateral A/F ratios no higher than peripheral. Of the 22 of these 37 who agreed to repeat AVS, 10 demonstrated unilateral aldosterone production, and eight of these had unilateral adrenalectomy disclosing APAs and resulting in cure (3) or improvement (5) in hypertension. Eight had bilateral aldosterone production. Four studies were inconclusive. Patients with initial unsatisfactory AVS because of bilaterally low A/F ratios had significantly (p=0.023) more unilateral disease [10 of 18 satisfactory repeat studies (55.6%) vs 326 of 1066 satisfactory initial studies (30.6%)] and a significantly higher (67.6% vs. 49.9%, p=0.034) percentage of males. Conclusions: Since the incidence of APAs was high in a subgroup with low A/F bilaterally on initial AVS, these patients should be offered repeat AVS. This might reflect both a greater dependence of aldosterone production on ACTH in APAs and the pulsatile nature of ACTH secretion. Powered by Editorial Manager and Preprint Manager from Aries Systems Corporation

*Manuscript 1 1 2 3 REPEATING ADRENAL VEIN SAMPLING WHEN NEITHER ALDOSTERONE/CORTISOL RATIO EXCEEDS PERIPHERAL YIELDS A HIGH INCIDENCE OF ALDOSTERONE-PRODUCING ADENOMA 4 5 6 7 8 Martin WOLLEY, Richard D. GORDON, Eduardo PIMENTA, Nicholas DAUNT, Gregory J. SLATER, Ashraf H. AHMED, Michael STOWASSER. Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia 9 10 11 12 13 14 15 16 17 18 Address correspondence to: Michael Stowasser Hypertension Unit University of Queensland School of Medicine Princess Alexandra hospital Ipswich road, Woolloongabba Brisbane 4102, Australia Telephone 61 7 31762694 Email m.stowasser@uq.edu.au 19 20 21 22 23 24 Short title: Repeat adrenal sampling if low aldosterone/cortisol ratios Conflicts of interest and source of funding: The authors have nothing to declare. No specific sources of funding were required for this research. Word count: 3010 Number of tables: One 1

2 25 ABSTRACT 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Objectives: In primary aldosteronism (PA), adrenal vein sampling (AVS) suggests unilateral aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is peripheral on one side and 2 times peripheral on the other. When A/F ratios are lower bilaterally than peripheral despite adequate samples (adrenal venous cortisol 3 times peripheral), we recommend repeat AVS. This study aimed to determine the frequency of this occurrence and outcomes in such cases. Methods: We performed a retrospective observational study of all cases of primary aldosteronism undergoing initial AVS over a 34 year period. Results: Initial AVS in 1397 patients returned satisfactory, discriminatory results in 1066 (76.3%) but 37 patients (2.6%) had adequate samples but bilateral A/F ratios no higher than peripheral. Of the 22 of these 37 who agreed to repeat AVS, 10 demonstrated unilateral aldosterone production, and eight of these had unilateral adrenalectomy disclosing APAs and resulting in cure (3) or improvement (5) in hypertension. Eight had bilateral aldosterone production. Four studies were inconclusive. Patients with initial unsatisfactory AVS because of bilaterally low A/F ratios had significantly (p=0.023) more unilateral disease [10 of 18 satisfactory repeat studies (55.6%) vs 326 of 1066 satisfactory initial studies (30.6%)] and a significantly higher (67.6% vs. 49.9%, p=0.034) percentage of males. Conclusions: Since the incidence of APAs was high in a subgroup with low A/F bilaterally on initial AVS, these patients should be offered repeat AVS. This might reflect both a greater dependence of aldosterone production on ACTH in APAs and the pulsatile nature of ACTH secretion. Key Words: Primary aldosteronism, adrenal vein sampling, aldosterone producing adenoma 2

3 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 INTRODUCTION Recognition of higher than previously expected rates of primary aldosteronism (PA) among hypertensives [1,2] was a major stimulus for the creation by The Endocrine Society in 2008 of international guidelines for case detection and investigation of PA [3]. Adrenal venous sampling (AVS) is important in the diagnostic process, distinguishing unilateral from bilateral aldosterone overproduction, with additional treatment options. AVS is a challenging procedure, requiring an experienced radiologist, and reported rates of successful cannulation of both adrenal veins vary from 42% to 98% [4,5]. Cannulating the right adrenal vein is frequently more difficult than the left, due to the small vessel size and its direct entry into the inferior vena cava, while the left adrenal vein usually joins the left phrenic vein which drains into the left renal vein. Confirmation of successful catheter placement requires comparison of adrenal and peripheral venous cortisol levels in order to correct for dilution from non-adrenal blood, with adrenal vein/peripheral vein cortisol ratios of at least 3.0 indicating satisfactory catheter placement [6]. Aldosterone/cortisol (A/F) ratios are then compared between adrenal and peripheral samples in order to differentiate unilateral from bilateral adrenal aldosterone overproduction, the former suggested by an A/F ratio lower than peripheral on one side (contralateral suppression) and an A/F ratio on the other side at least two-fold higher than peripheral [6]. 68 69 70 71 72 73 74 Fortunately only rarely, in our experience, A/F ratios bilaterally are found to be no higher than peripheral, despite cortisol gradients confirming successful adrenal vein cannulation, a result that is uninterpretable in regard to lateralisation of aldosterone production. The frequency of this occurrence, the best subsequent management and the likely outcomes have to our knowledge never been documented. The aim of this study therefore was to retrospectively analyse our AVS database to identify such cases of primary aldosteronism where adequate cannulation of both adrenal veins was demonstrated but no increase in the 3

4 75 76 A/F ratio on either side found during adrenal vein sampling. We further examined these cases to identify the results of further testing and outcomes. 77 78 METHODS 79 Setting and subjects 80 81 82 83 This study was performed in the Hypertension Units of the Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia. Using a prospectively updated database, results of AVS between January 1978 and February 2012 were searched for those with bilaterally low A/F ratios on initial sampling. 84 Diagnosis of primary aldosteronism 85 86 87 88 89 90 91 92 93 94 95 96 97 The diagnosis of PA was established according to our previously published criteria [7]. Interfering medications (diuretics, beta blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists and dihydropyridine calcium channel antagonists) were stopped, if possible, at least 4 weeks prior to testing (6 weeks in the case of diuretics including spironolactone). Patients with an elevated aldosterone/renin ratio on at least 2 occasions (>70 with plasma aldosterone in picomoles/liter and plasma active renin in milliunits/liter or >590 with plasma renin activity in ng/ml/hr) underwent fludrocortisone suppression testing to confirm PA. Fludrocortisone suppression testing was regarded as positive if the aldosterone level at 10:00 am after at least 2 hours of upright posture was 165pmol/L after 4 days of oral salt loading with concurrent fludrocortisone administration (0.1mg 6 hourly), providing that (1) upright renin was suppressed to less than 8.4mU/L, (2) plasma potassium was within the normal range (sufficient oral potassium chloride 6 hourly to keep plasma potassium measured at least three times daily as close as possible to 4

5 98 99 4.0mmol/L) and (3) plasma cortisol was lower at 1000 h than at 0800h, excluding an acute increase in ACTH preventing suppression of aldosterone. 100 Adrenal vein sampling 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 This study was restricted to those in whom bilateral adrenal vein cannulation was attempted. Adrenal vein sampling was performed between 8 and 11am after overnight recumbency and without ACTH stimulation. Sequential cannulation of both adrenal veins was performed by no more than three experienced radiologists in either hospital (six in total). Usually a short time (<15mins) elapsed between sampling of the left and right adrenal veins. Gradients of 3 between adrenal and peripheral venous cortisol concentrations were taken to indicate adequate sampling. If the A/F ratio on one side was 2 times the simultaneously collected peripheral ratio and on the other side was the same or less than peripheral (contralateral suppression), the study was considered to demonstrate lateralization of aldosterone production. Adrenal venous A/F ratios higher than peripheral on both sides were taken to indicate bilateral aldosterone production. When results of AVS were inconclusive (comprising unsuccessful cannulation of either adrenal vein or A/F ratios no higher than peripheral bilaterally), repeat AVS was offered to the patient. Computed tomography (CT) of the adrenals with slices 2-3 mm apart was always performed prior to adrenal vein sampling in order to identify any adrenal lesions and to localize adrenal veins and thus assist in successful cannulation [5]. 117 Outcomes 118 119 120 121 Hospital records were examined to determine patient outcome. Data were collected on patient demographic details, AVS results, serum potassium on presentation and follow up, blood pressure and medications before and after unilateral adrenalectomy or commencement of aldosterone blocking medications. 5

6 122 123 124 125 126 127 128 129 Hypertension was defined as cured if BP was 140/90 mm Hg or less without antihypertensive medications and improved if fewer medications were needed, provided that the dosage of none of the medications was increased, or if the dosage of one or more medications could be reduced, provided that no additional medications were added. Patients were regarded as not improved if the same or a greater number or antihypertensives were needed to achieve the same BP or if the BP was higher. When patients had a repeat FST after unilateral adrenalectomy (commencing February 1996), demonstration of normal suppressiblity of aldosterone was taken to indicate biochemical cure of PA [8]. 130 Statistics 131 132 133 134 The data were analysed using Statistica 10 (Statsoft. Inc Tulsa).Standard descriptive statistics were employed for demographic data. For non-parametrically distributed data medians were compared using the Mann-Whitney U test. Proportions between groups were compared using the chi-square test. A p value <0.05 was considered statistically significant. 135 136 RESULTS 137 Patient characteristics and frequency of bilateral low A/F ratios. 138 139 140 Of 1397 patients with PA who underwent an initial AVS, 37 (2.6%) had adrenal venous A/F ratios the same or lower than peripheral on both sides. Of the remaining initial studies, 1066 were conclusive and 294 (21%) were inconclusive. 141 142 143 The demographics, results of CT examination, presence of pre-treatment hypokalemia, results of repeat AVS, histology and outcomes in terms of BP and repeat fludrocortisone suppression testing (if performed) after unilateral adrenalectomy for the 37 patients are shown in table 1. 6

7 144 145 146 There was a significantly (p=0.034) higher percentage of males among the 37 with low A/F ratios bilaterally than among the remaining patients undergoing AVS [25/37 (67.6%) vs. 679/1360 (49.9%)]. Median ages were similar (54.0 vs 53.5 years, p=0.38). 147 Outcomes 148 149 150 151 152 While 15 patients declined a repeat study, 22 of the 37 patients with bilaterally low initial A/F ratios underwent repeat AVS. Ten of these were consistent with unilateral and eight with bilateral aldosterone production. Four studies were again inconclusive, two due to failure to successfully cannulate one or both adrenal veins and two due to bilateral low A/F ratios for a second time. 153 154 155 A similar proportion of those who declined repeat AVS compared to those who repeated AVS had hypokalemia (9/15 vs. 11/22 p=0.55), evidence of adrenal adenoma on CT where available (8/12 vs. 12/19 p=0.82), and were of male gender (9/15 vs 16/22 p=0.42). 156 157 158 159 160 Eight of the ten patients showing unilateral aldosterone production went on to unilateral adrenalectomy. Four of the five who had follow-up FST had a biochemical cure and the fifth had residual but reduced unsuppressible aldosterone production. The five who had been hypokalemic became normokalemic, and hypertension was cured in three and improved in the other five. 161 162 163 164 165 166 The possibility of unilateral APA was considered and discussed with five additional patients with unsatisfactory initial AVS on the basis of a unilateral mass lesion on CT and hypokalaemia (patients 19, 23, 24, 25 and 26). Four had declined a second AVS and one had an inconclusive second AVS. They all chose unilateral adrenalectomy. Two had a follow up FST which confirmed biochemical cure. Hypertension was cured in two and improved in three. 7

8 167 168 169 170 171 172 When repeat AVS was consistent with bilateral aldosterone production (n=8), specific medical treatment was commenced with either spironolactone or amiloride or both, with correction of hypokalemia in the four initially hypokalemic and improvement of hypertension in all. Three of these patients eventually went on to unilateral adrenalectomy because of a poor long term blood pressure response or intolerance to medical therapy. In these cases the side with higher aldosterone production was removed. 173 174 175 There was a significantly higher frequency of unilateral disease (10/18 [55.6%] vs. 326/1066 [30.6%], p=0.023) in the subgroup with bilaterally low A/F on initial AVS than in the 1066 with initial diagnostic AVS. 176 177 DISCUSSION 178 179 180 181 182 As far as we are aware, this is the first report suggesting that repeat AVS in cases where the initial study was compromised by bilateral low adrenal venous A/F ratios yields a high incidence of unilateral PA with worthwhile clinical and biochemical responses to unilateral adrenalectomy. A higher percentage of males in this subgroup was an additional unexpected finding. 183 184 185 186 187 188 There is no immediately obvious explanation for the higher incidence of unilateral disease in the PA patients with failed AVS due to bilaterally quiescent secretion of aldosterone. ACTH is secreted episodically in pulses, reflected in the pattern of cortisol levels revealed by frequent, 20 minute sampling [9]. Aldosterone secretion in patients with APA has been shown to have an episodic or pulsatile pattern of release, and it has been suggested that this is more disorderly than in normal subjects [10]. While it has been suggested that APAs are 8

9 189 190 more responsive to ACTH than the adrenals of patients with bilateral overproduction of aldosterone [11,12], there is also published evidence contradicting this [13]. 191 192 193 194 195 196 197 198 If renin-angiotensin is chronically severely suppressed in PA, which happens more commonly in APA than in bilateral PA, then responses to other regulators such as ACTH and potassium may become more prominent and recognisable. Secretion normally resulting from angiotensin stimulation will be minimal, significantly lowering adrenal venous concentrations, so that any periods of quiescence in episodic ACTH secretion will be accompanied by very low aldosterone secretion and be more recognisable. This is perhaps what we are seeing in the patients with failed AVS despite good cannula placement, and might explain why more of them than expected have unilateral APAs. 199 200 201 202 203 Errors arising during assay of aldosterone and cortisol can never be completely excluded but evidence to suggest this was not found in the cases in question. Explanations such as anomalous venous drainage of the adrenals [5,14 16], accidental super-selective adrenal sampling [17], or extra-adrenal aldosterone producing tumours are unlikely given the results of repeat AVS. 204 205 206 The preponderance of males in those with bilaterally low A/F ratios during AVS is an unexpected finding and has no obvious explanation. Possibly this was a chance finding due to the small number of cases. 207 208 209 210 211 212 A significant limitation of this study is its retrospective nature which, for example, may have increased the risk of selection bias when considering subjects for repeat AVS. The percentages of patients with adrenal lesions on CT and/or with hypokalemia in the subgroups accepting repeat AVS and those not accepting were not different. This makes it improbable that stronger arguments in favour of repeat AVS were used for those thought at the time more likely to have an APA. 9

10 213 214 215 216 217 218 The principal finding in the present study was that, despite failure of the initial AVS to contribute to a diagnosis, repeat AVS was usually successful. Eighteen of 22 repeat AVS were diagnostic. This is perhaps surprising, and suggests that the initial sampling during quiescent aldosterone secretion was presumably due to chance (and episodic ACTH secretion) rather than a permanent idiosyncratic particularity of adrenal function in these patients. 219 220 221 222 223 224 225 226 227 228 229 230 231 232 Some units employ ACTH stimulation of aldosterone secretion with an intravenous bolus immediately before, or a continuous infusion during, AVS sampling [18,19]. The aim is to maximise the sensitivity of the procedure, ensuring active secretion of both cortisol and aldosterone by both adrenals during sample collection. Rossi et al reported that an ACTH bolus (250mcg) before AVS consistently increased aldosterone production by the contralateral adrenal but less consistently from the ipsilateral APA, reducing successful lateralization [20]. The same group studied varied bolus doses of ACTH, reporting a favourable increase in the selectivity index with higher doses of ACTH, but again counterbalanced, unfortunately, by a confounding effect on correct lateralisation of APA [21]. There has been some criticism of this study because of unusually permissive criteria for successful sampling and lateralisation [22]. A multicentre study (three Units, 76 patients) employing either ACTH bolus or infusion found that ACTH stimulation increased rates of successful bilateral cannulation from 49% to 87%, without significantly reducing accuracy of discrimination between unilateral and bilateral disease [23]. 233 234 235 236 237 While we cannot answer the question whether ACTH stimulation during AVS would have reduced the already low incidence of bilaterally quiescent aldosterone secretion, it is reasonable to suggest that it might have. We have therefore recently changed our protocol for repeat AVS only, following bilateral low adrenal vein/peripheral vein aldosterone/cortisol ratios at initial AVS. This involves collection of two full sets of samples, the first without 10

11 238 239 240 241 242 ACTH stimulation and the second with ACTH stimulation. If the first samples without ACTH stimulation are satisfactory, those results are accepted as definitive, since any possible compromise due to loss of contralateral suppression following ACTH stimulation is avoided. The additional samples collected after ACTH are only utilised in diagnosis if those before ACTH again showed low aldosterone cortisol ratios versus peripheral bilaterally. 243 244 245 246 247 248 249 250 To conclude, in this study we examined an infrequent but difficult clinical problem; when, despite unequivocal evidence of primary aldosteronism, adrenal vein sampling fails to demonstrate elevated aldosterone/cortisol ratios on either side. It appears that persistence in pursuing a diagnosis in this group yields unexpectedly high rates of potentially curable APA. It seems likely that the problem is associated with quiescent periods in ACTH secretion, which may be more common in males than females. We recommend always encouraging the patient to have repeat AVS in this situation. We are prospectively examining the use of ACTH stimulation in repeat studies, with sampling both before and after ACTH. 251 252 11

12 253 Table 1. Demographic details and outcomes in patients with bilaterally low A/F ratios on initial AVS Patient Age at diagnosis (y) Gender Result of second attempt at AVS* Nodule on Hypokalemia Treatment # Blood pressure Adrenal CT + outcome Tumor size (cm) Post op FST 1 63 M Right Y N Adrenalectomy Improved 1.1-2 43 M Right Y Y Adrenalectomy Cure 0.8 Cure 3 56 F Right - Y Medical Improved - - 4 64 F Right Y Y Adrenalectomy Improved 1.3-5 41 M Right N N Adrenalectomy Improved NH Improved 6 48 M Left Y N Adrenalectomy Cure 0.5 Cure 7 46 M Left Y N Adrenalectomy Cure 0.8 Cure 8 52 M Right Y N Adrenalectomy Improved 1.8-9 54 M Right N Y Medical Improved - - 10 56 M Left Y Y Adrenalectomy Improved 1.8, 1.0 Cure 11 42 M Bilat N N Adrenalectomy Improved NH - 12 54 M Bilat Y Y Medical Improved - - 13 57 F Bilat - N Medical Improved - - 14 55 F Bilat N N Medical Improved - - 15 21 M Bilat - N Medical Improved - - 16 57 F Bilat Y Y Adrenalectomy Improved 0.8-17 47 F Bilat N Y Medical Improved - - 18 59 M Bilat Y Y Adrenalectomy Improved 1.0-19 55 M Unsuccessful Y Y Adrenalectomy Improved 1.8-20 61 M Low Y Y Medical Improved - - 21 35 M Low N N Medical Improved - - 22 49 M Unsuccessful N N Medical Improved - - 23 58 F - Y Y Adrenalectomy Improved 1.8-24 47 M - Y Y Adrenalectomy Cure NH Cure 12

13 254 255 25 54 F - Y Y Adrenalectomy Improved 2.0-26 53 M - Y Y Adrenalectomy Cure 1.0 Cure 27 61 F - N N Medical Improved - - 28 56 F - Y Y Medical Improved - - 29 64 M - N Y Medical Improved - - 30 45 M - - Y Medical Improved - - 31 38 M - Y N Medical Improved - - 32 60 M - - N Medical Improved - - 33 58 F - N N Medical Improved - - 34 45 M - - Y Medical Improved - - 35 52 M - Y Y Medical Not Improved - - 36 55 M - N N Medical Improved - - 37 46 F - Y N Medical Improved - - * Right/Left indicates AVS lateralised to one side, Bilat indicates bilateral production, Low indicates bilaterally low A/F ratios, Unsuccessful indicates that one side was not successfully cannulated. 256 + Y indicates abnormal appearances on an adrenal CT consistent with an adenoma, on the same side if AVS lateralised. 257 # Medical indicates treatment with specific aldosterone blocking drug; spironolactone, amiloride or both. 258 NH indicates nodular hyperplasia. 259 260 261 "Cure" indicates normal suppression of plasma aldosterone during postoperative fludrocortisone suppression testing, "Improved" indicates failure of normal suppression of plasma aldosterone during postoperative FST (consistent with residual autonomous aldosterone production) but with day four FST plasma aldosterone levels lower than pre-operatively. 13

14 262 REFERENCES 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 1 Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21:315 318. 2 Mulatero P, Stowasser M, Loh K-C, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89:1045 1050. 3 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93:3266 3281. 4 Harvey A, Kline G, Pasieka JL. Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with less than ideal testing. Surgery 2006; 140:847 853; discussion 853 855. 5 Daunt N. Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful. Radiographics 2005; 25:S143 S158. 6 Mulatero P, Bertello C, Sukor N, Gordon R, Rossato D, Daunt N, et al. Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism. Hypertension 2010; 55:667 673. 7 Stowasser M, Taylor PJ, Pimenta E, Ahmed AHA-A, Gordon RD. Laboratory Investigation of Primary Aldosteronism. Clin Biochem Rev 2010; 31:39 56. 8 Rutherford JC, Taylor WL, Stowasser M, Gordon RD. Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg 1998; 22:1243 1245. 9 Lacerda LD, Kowarski A, Migeon CJ. Integrated Concentration and Diurnal Variation of Plasma Cortisol. J Clin Endocrinol Metab 1973; 36:227 238. 10 Siragy HM, Vieweg WV, Pincus S, Veldhuis JD. Increased Disorderliness and Amplified Basal and Pulsatile Aldosterone Secretion in Patients with Primary Aldosteronism. J Clin Endocrinol Metab 1995; 80:28 33. 11 Ganguly A, Melada GA, Luetscher JA, Dowdy AJ. Control of Plasma Aldosterone in Primary Aldosteronism: Distinction Between Adenoma and Hyperplasia. J Clin Endocrinol Metab 1973; 37:765 775. 12 Guthrie GP Jr. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism. J Lab Clin Med 1981; 98:364 373. 13 Stowasser M, Klemm SA, Tunny TJ, Gordon RD. Plasma aldosterone response to ACTH in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 1995; 22:460 462. 14

15 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 14 Gagnon R. The venous drainage of the human adrenal gland. Rev Can Biol 1956; 14:350 359. 15 Monkhouse WS, Khalique A. The adrenal and renal veins of man and their connections with azygos and lumbar veins. J Anat 1986; 146:105 115. 16 Parnaby CN, Galbraith N, O Dwyer PJ. Experience in identifying the venous drainage of the adrenal gland during laparoscopic adrenalectomy. Clinl Anatomy 2008; 21:660 665. 17 Omura M, Makita K, Yamaguchi K, Sasano H, Nishikawa T. A new method of superselective acth-stimulated adrenal venous sampling is revolutionarily useful for treatment of primary aldosteronism: PP.18.179. J Hypertens 2010; 28:1. 18 Young Jr. WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136:1227 1235. 19 Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 2012; 97:1606 1614. 20 Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, et al. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 2006; 24:371 379. 21 Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, et al. Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling for Identifying Surgically Curable Subtypes of Primary Aldosteronism Comparison of 3 Different Protocols. Hypertension 2009; 53:761 766. 22 Tanemoto M, Mishima E, Takeuchi Y, Abe T. Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling. Hypertension 2009; 54:e23 e23. 23 Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo M, et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension 2012; 59:840 846. 326 15

Reviewer strengths and weaknesses (JOURNAL OFFICE USE ONLY) JH-D-13-00085 (M. Wolley et al.) Reviewers Summary Evaluations Referee 1 Adrenal sampling (AVS) is an essential tool in assessment of primary aldosteronism (PA) in order to diagnose an aldosterone-producing adenoma (APA) suitable form for surgery. When the aldosterone/cortisol (A/F) ratio is lower bilaterally than peripheral, AVS should be repeated; the Authors showed high incidence of APAs in patients with prior AVS incomplete, suggesting the significance of repeat AVS. Referee 2 Primary aldosteronism is a frequent cause of identifiable and resistant hypertension. Screening for this potentially curable disorder has evolved with better endocrinologic criteria and adrenal imaging. Laparoscopic surgery is highly effective for excision of Conn s tumors. However, surgical cure depends on pre-operative localization, by adrenal venous sampling, to avoid wrong-side surgery. The summary by Wolley et al of their very large series tells an important lesson: If at first, you don t succeed, try, and try again. However, the expertise that a large experience conveys implies that interventional management of primary aldosteronism is best conducted in appropriate referral centers.

*Condensed abstract Condensed abstract This retrospective observational study of adrenal vein sampling (AVS) for primary aldosteronism reviewed 1397 AVS done with consistent protocols over a 34 year period to examine the frequency of cases where adequate samples were obtained but bilaterally low aldosterone production was demonstrated. This occurred in 37 (2.6%) cases and 22 of these underwent a repeat study, demonstrating 10 unilateral aldosterone producing adenoma (APA), 8 cases of bilateral disease and 4 inconclusive repeat studies. Since the incidence of APA was high in this subgroup, these patients should always be offered a repeat AVS.

*Abbreviations definition list Abbreviations definitions list PA = Primary aldosteronism AVS = Adrenal vein sampling APA = Aldosterone producing adenoma A/F ratio = Aldosterone/cortisol ratio ACTH = Adrenocorticotrophic hormone CT = Computed tomography

*LWW Copyright Transfer and Disclosure Form Click here to download LWW Copyright Transfer and Disclosure Form: copyrighttransfer MW.pdf